Key result
CRISPR screening identifies RPP24 and RPP64 as unique RNase MRP components essential for pre-rRNA processing.
Why the study?
All known protein components of human nuclear Ribonuclease MRP were shared with Ribonuclease P, leaving MRP-specific protein components unidentified.
The study identifies RPP24 and RPP64 as the first two protein components unique to human nuclear RNase MRP.
SUMMARY All known protein components of one of the longest-studied human ribonucleoprotein ribozyme nuclear Ribonuclease MRP (RNase MRP), which processes pre-rRNA at ITS1 site 2, are shared with Ribonuclease P (RNase P), which cleaves pre-tRNA 5′ leader sequences. Our genome-wide forward genetic screening identified two poorly characterized human genes, which we named RPP24 and RPP64. We show that these two genes are required for pre-rRNA ITS1 site 2 processing and their protein products efficiently associate with RNA MRP. Unlike all other human RNase MRP protein components, RPP24 and RPP64 are not required for RNase P activity and do not associate with RNase P-specific RNA H1. Despite extremely limited sequence homology, RPP24 and RPP64 exhibit predicted structural similarities to two RNase MRP-specific components in S. cerevisiae , with specific differences in RPP64 regions of substrate recognition. Collectively, our functional screening and validation revealed the first two protein components unique to human nuclear RNase MRP.
No takes yet. Share an insight, caveat, or question.
Che et al. (2025) studied this question. CRISPR knockout of RPP24 and RPP64 vs. Control knockouts was evaluated on Levels of unprocessed pre-rRNA precursor at ITS1 site 2 (5.9- and 11.6-fold increase). Genome-wide CRISPR screening identified RPP24 and RPP64 as the first two human protein components unique to nuclear RNase MRP, required for pre-rRNA processing but not RNase P activity.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: